SCGB2A2 and breast cancer: Mammaglobin-A downregulation has been documented in 49% of breast cancers by Zafrakas et al. [14] comparing normal and tumor tissues, and our data shows the complete absence of mammaglobin-A staining in 46% of NST cancers, while normal breast epithelium usually showed detectable staining.